Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?

Background. During ECMO, anticoagulants, in particular, unfractionated heparin (UFH), are commonly used and monitored by laboratory tests, including ACT, APTT, and anti-Xa level. Method. A single-center retrospective observational study was conducted on adult patients undergoing ECMO between January...

Full description

Saved in:
Bibliographic Details
Main Authors: Tung Phi Nguyen, Xuan Thi Phan, Dai Quang Huynh, Ha Thi Viet Truong, Yen Nguyen Hai Le, Tuan Manh Nguyen, Quan Quoc Minh Du, Thao Phuong Le, Hai Ngoc Truong, Thi Thi Ho, Thao Thi Ngoc Pham
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/5579936
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555234047557632
author Tung Phi Nguyen
Xuan Thi Phan
Dai Quang Huynh
Ha Thi Viet Truong
Yen Nguyen Hai Le
Tuan Manh Nguyen
Quan Quoc Minh Du
Thao Phuong Le
Hai Ngoc Truong
Thi Thi Ho
Thao Thi Ngoc Pham
author_facet Tung Phi Nguyen
Xuan Thi Phan
Dai Quang Huynh
Ha Thi Viet Truong
Yen Nguyen Hai Le
Tuan Manh Nguyen
Quan Quoc Minh Du
Thao Phuong Le
Hai Ngoc Truong
Thi Thi Ho
Thao Thi Ngoc Pham
author_sort Tung Phi Nguyen
collection DOAJ
description Background. During ECMO, anticoagulants, in particular, unfractionated heparin (UFH), are commonly used and monitored by laboratory tests, including ACT, APTT, and anti-Xa level. Method. A single-center retrospective observational study was conducted on adult patients undergoing ECMO between January 2019 and January 2020 at a tertiary hospital. The correlations between ACT, APTT, anti-Xa, antithrombin, and UFH dose were assessed. Results. 129 sets of measurements from 37 patients were obtained including ACT, APTT, anti-Xa, antithrombin, and UFH dose measured simultaneously. 102 out of 129 sets of values were interpreted as antithrombin deficiencies. The correlation coefficient between APTT and anti-Xa; ACT and anti-Xa are 0.72 and 0.33, respectively, p<0.001. The patients with normal antithrombin levels exhibited a significant correlation between APTT and anti-Xa (r = 0.80, p<0.001). ACT, on the other hand, was poorly correlated with UFH dose, whether there is AT deficiency or not. Anti-Xa and APTT are only moderately correlated with UFH dose in the group without antithrombin deficiency, with correlation coefficients of 0.62 and 0.57, respectively, p<0.05. Conclusion. APTT value is strongly correlated with anti-Xa value, particularly in patients with normal antithrombin levels. However, the ACT value was poorly correlated with anti-Xa and not with the UFH dose. In groups without antithrombin deficiency, APTT and anti-Xa values only moderately correlated with UFH dose.
format Article
id doaj-art-1e7c885785d741b88635d48acbb1954e
institution Kabale University
issn 2090-1305
2090-1313
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Critical Care Research and Practice
spelling doaj-art-1e7c885785d741b88635d48acbb1954e2025-02-03T05:49:16ZengWileyCritical Care Research and Practice2090-13052090-13132021-01-01202110.1155/2021/55799365579936Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?Tung Phi Nguyen0Xuan Thi Phan1Dai Quang Huynh2Ha Thi Viet Truong3Yen Nguyen Hai Le4Tuan Manh Nguyen5Quan Quoc Minh Du6Thao Phuong Le7Hai Ngoc Truong8Thi Thi Ho9Thao Thi Ngoc Pham10Department of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamIntensive Care Unit, Cho Ray Hospital, Ho Chi Minh City, VietnamIntensive Care Unit, Cho Ray Hospital, Ho Chi Minh City, VietnamIntensive Care Unit, Cho Ray Hospital, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamIntensive Care Unit, Cho Ray Hospital, Ho Chi Minh City, VietnamDepartment of Intensive Care, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, VietnamBackground. During ECMO, anticoagulants, in particular, unfractionated heparin (UFH), are commonly used and monitored by laboratory tests, including ACT, APTT, and anti-Xa level. Method. A single-center retrospective observational study was conducted on adult patients undergoing ECMO between January 2019 and January 2020 at a tertiary hospital. The correlations between ACT, APTT, anti-Xa, antithrombin, and UFH dose were assessed. Results. 129 sets of measurements from 37 patients were obtained including ACT, APTT, anti-Xa, antithrombin, and UFH dose measured simultaneously. 102 out of 129 sets of values were interpreted as antithrombin deficiencies. The correlation coefficient between APTT and anti-Xa; ACT and anti-Xa are 0.72 and 0.33, respectively, p<0.001. The patients with normal antithrombin levels exhibited a significant correlation between APTT and anti-Xa (r = 0.80, p<0.001). ACT, on the other hand, was poorly correlated with UFH dose, whether there is AT deficiency or not. Anti-Xa and APTT are only moderately correlated with UFH dose in the group without antithrombin deficiency, with correlation coefficients of 0.62 and 0.57, respectively, p<0.05. Conclusion. APTT value is strongly correlated with anti-Xa value, particularly in patients with normal antithrombin levels. However, the ACT value was poorly correlated with anti-Xa and not with the UFH dose. In groups without antithrombin deficiency, APTT and anti-Xa values only moderately correlated with UFH dose.http://dx.doi.org/10.1155/2021/5579936
spellingShingle Tung Phi Nguyen
Xuan Thi Phan
Dai Quang Huynh
Ha Thi Viet Truong
Yen Nguyen Hai Le
Tuan Manh Nguyen
Quan Quoc Minh Du
Thao Phuong Le
Hai Ngoc Truong
Thi Thi Ho
Thao Thi Ngoc Pham
Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
Critical Care Research and Practice
title Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
title_full Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
title_fullStr Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
title_full_unstemmed Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
title_short Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
title_sort monitoring unfractionated heparin in adult patients undergoing extracorporeal membrane oxygenation ecmo act aptt or anti xa
url http://dx.doi.org/10.1155/2021/5579936
work_keys_str_mv AT tungphinguyen monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT xuanthiphan monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT daiquanghuynh monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT hathiviettruong monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT yennguyenhaile monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT tuanmanhnguyen monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT quanquocminhdu monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT thaophuongle monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT haingoctruong monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT thithiho monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa
AT thaothingocpham monitoringunfractionatedheparininadultpatientsundergoingextracorporealmembraneoxygenationecmoactapttorantixa